Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice

Journal of Virology

Volumn 81, Issue 19, 2007, Pages 10310-10315

  Wu, Te Chia ^a   Wang, Ya Fang ^a   Lee, Yi Ping ^a   Wang, Jen Ren ^a   Liu, Ching Chuan ^b   Wang, Shih Min ^b   Lei, Huan Yao ^a   Su, Ih Jen ^a,c   Yu, Chun Keung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; COXSACKIE VIRUS A; COXSACKIE VIRUS B3; CROSS REACTION; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; VIRUS LOAD; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; B-LYMPHOCYTES; CROSS REACTIONS; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; IMMUNIZATION, PASSIVE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED ICR; T-LYMPHOCYTES; VACCINATION; VIRAL LOAD; VIRAL VACCINES;

ENTEROVIRUS; HUMAN ENTEROVIRUS 71; MURINAE; MUS; POLIOVIRUS;

EID: 34648819319     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00372-07     Document Type: Article

References (24)

1. CDC. 2005. Epidemiology bulletin, vol. 21. CDC, Taiwan, Republic of China.
2. Chan, Y. F., and S. AbuBakar. 2004. Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerg. Infect. Dis. 10:1468-1470.
3. Chehadeh, W., A. Bouzidi, G. Alm, P. Wattre, and D. Hober. 2001. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro. J. Gen. Virol. 82:1899-1907.
4. Chen, H. F., M. H. Chang, B. L. Chiang, and S. T. Jeng. 2006. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 24:2944-2951.
5. Girn, J., M. Kavoosi, and J. Chantler. 2002. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J. Gen. Virol. 83:351-358.
6. Hagiwara, A., Tagaya, I., and T. Yoneyama. 1978. Common antigen between coxsackievirus A16 and enterovirus 71. Microbiol. Immunol. 22:81-88.
7. Ho, M. 2000. Enterovirus 71: the virus, its infections, and outbreaks. J. Microbiol Immunol Infect. 33:205-216.
8. Hsiung, G. D. 1994. Hsiung's diagnostic virology. Yale University Press, New Haven, CT.
9. Juhela, S., H. Hyoty, M. Lonnrot, M. Roivainen, O. Simell, and J. Honen. 1998. Enterovirus infections and enterovirus specific T-cell responses in infancy. J. Med. Virol. 54:226-232.
10. Kishimoto, C., M. Kurokawa, and H. Ochiai. 2002. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J. Mol. Cell. Cardiol. 34:1227-1238.
11. Liu, M. L., Y. P. Lee, Y. F. Wang, H. Y. Lei, C. C. Liu, S. M. Wang, I. J. Su, J. R. Wang, T. M. Yeh, S. H. Chen, and C. K. Yu. 2005. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86:3263-3269.
12. Lukashev, A. N. 2005. Role of recombination in evolution of enteroviruses. Rev. Med. Virol. 15:157-167.
13. McMinn, P. C. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91-107.
14. Oberste, M. S., K. Maher, and M. A. Pallansch. 2004. Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J. Virol. 78:855-867.
15. Oberste, M. S., S. Penaranda, K. Maher, and M. A. Pallansch. 2004. Complete genome sequences of all members of the species human enterovirus A. J. Gen. Virol 85:1597-1607.
16. Siegrist, C. A. 2001. Neonatal and early life vaccinology. Vaccine 19:3331-3346.
17. Uhlig, H., and R. Dernick. 1988. Intertypic cross-neutralization of polioviruses by human monoclonal antibodies. Virology 163:214-217.
18. Wang, J. R., Y. C. Tuan, H. P. Tsai, J. J. Yan, C. C. Liu, and I. J. Su. 2002. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J. Clin. Microbiol 40:10-15.
19. Wang, S. M., H. Y. Lei, M. C. Huang, J. M. Wu, C. T. Chen, J. N. Wang, J. R. Wang, and C. C. Liu. 2005. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr. Pulmonol. 39:219-223.
20. Wang, S. M., H. Y. Lei, M. C. Huang, L. Y. Su, H. C. Lin, C. K. Yu, J. L. Wang, and C. C. Liu. 2006. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J. Clin. Virol. 37:47-52.
21. Wang, Y. F., C. T. Chou, H. Y. Lei, C. C. Liu, S. M. Wang, J. J. Yan, I. J. Su, J. R. Wang, T. M. Yeh, S. H. Chen, and C. K. Yu. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78:7916-7924.
22. Wu, C. N., Y. C. Lin, C. Fann, N. S. Liao, S. R. Shih, and M. S. Ho. 2001. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20: 895-904.
23. Yan, J. J., I. J. Su, P. F. Chen, C. C. Liu, C. K. Yu, and J. R. Wang. 2001. Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J. Med. Virol. 65:331-339.
24. Yu, C. K., C. C. Chen, C. L. Chen, J. R. Wang, C. C. Liu, J. J. Yan, and I. J. Su. 2000. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J. Biomed. Sci. 7:523-528.